SARS‐CoV‐2 variants and vulnerability at the global level
Numerous variants of the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)
pandemic have evolved. Viral variants may evolve with harmful susceptibility to the immunity …
pandemic have evolved. Viral variants may evolve with harmful susceptibility to the immunity …
Fast-track development of vaccines for SARS-CoV-2: the shots that saved the world
In December 2019, an outbreak emerged of severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) which leads to coronavirus disease 2019 (COVID-19). The World Health …
2 (SARS-CoV-2) which leads to coronavirus disease 2019 (COVID-19). The World Health …
Recent review of COVID-19 management: Diagnosis, treatment and vaccination
The idiopathic Coronavirus disease 2019 (COVID-19) pandemic outbreak caused by the
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has reached global …
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has reached global …
Global impact of delta plus variant and vaccination
VP Chavda, V Apostolopoulos - Expert Review of Vaccines, 2022 - Taylor & Francis
The coronavirus, like all viruses, has mutated numerous times since it first appeared in
China in late 2019. Throughout the pandemic, a number of variants have surfaced, changing …
China in late 2019. Throughout the pandemic, a number of variants have surfaced, changing …
Therapeutic monoclonal antibodies for COVID-19 management: an update
VP Chavda, R Prajapati, D Lathigara… - Expert opinion on …, 2022 - Taylor & Francis
Background The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has
affected more than 529 million people, and today the world is facing different mutant strains …
affected more than 529 million people, and today the world is facing different mutant strains …
Replicating viral vector-based vaccines for COVID-19: potential avenue in vaccination arena
The “severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)” is the third member of
human coronavirus (CoV) that is held accountable for the current “coronavirus disease 2019 …
human coronavirus (CoV) that is held accountable for the current “coronavirus disease 2019 …
Adenoviral vector-based vaccine platform for COVID-19: Current status
The coronavirus disease (COVID-19) breakout had an unimaginable worldwide effect in the
21st century, claiming millions of lives and putting a huge burden on the global economy …
21st century, claiming millions of lives and putting a huge burden on the global economy …
Is booster dose strategy sufficient for omicron variant of SARS-CoV-2?
VP Chavda, V Apostolopoulos - Vaccines, 2022 - mdpi.com
The Omicron variant of SARS-CoV-2 is emerging in communities where people were
previously infected with SARS-CoV-2 and are now being vaccinated, or where many people …
previously infected with SARS-CoV-2 and are now being vaccinated, or where many people …
COVID-19 and vaccination: myths vs science
Introduction Several vaccines against severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) have been developed since the inception of the coronavirus disease 2019 …
(SARS-CoV-2) have been developed since the inception of the coronavirus disease 2019 …
Are nutraceuticals effective in COVID-19 and post-COVID prevention and treatment?
A Catalano, D Iacopetta, J Ceramella, ACD Maio… - Foods, 2022 - mdpi.com
The beginning of the end or the end of the beginning? After two years mastered by
coronavirus disease 19 (COVID-19) pandemic, we are now witnessing a turnaround. The …
coronavirus disease 19 (COVID-19) pandemic, we are now witnessing a turnaround. The …